Table 3.
Antibiotic susceptibility profiles of 172 GBS isolates from pregnant women.
| Antibiotic | Total | S (%) | I (%) | R (%) | NS (%) |
|---|---|---|---|---|---|
| Amoxicillin | 172 | 171(99.4) | NA | NA | 1(0.6) |
| Erythromycin | 172 | 34(19.8) | 0(0.0) | 138(80.2) | NA |
| Clindamycin | 172 | 40(23.3) | 3(1.7) | 129(75.0) | NA |
| Tetracycline | 172 | 73(42.4) | 0(0.0) | 99(57.6) | NA |
| Chloramphenicol | 172 | 149(86.6) | 0(0.0) | 23(13.4) | NA |
| Levofloxacin | 172 | 59(34.3) | 1(0.6) | 112(65.1) | NA |
| Penicillin | 172 | 171(99.4) | NA | NA | 1(0.6) |
| Cefotaxime | 172 | 170(98.8) | NA | NA | 2(1.2) |
| Cefepime | 172 | 170(98.8) | NA | NA | 2(1.2) |
| Meropenem | 172 | 171(99.4) | NA | NA | 1(0.6) |
| Vancomycin | 172 | 172(100.0) | NA | NA | 0(0.0) |
| Linezolid | 172 | 172(100.0) | NA | NA | 0(0.0) |
S: susceptible, I: intermediate, R: resistance, NS: nonsusceptible, NA: not applicable.